Antibiotics Simplified

Title Page
Copyright Page
Contents
Acknowledgments
Introduction
New to the Fifth Edition
Chapter 1: The Wonderful World of Microbiology
Chapter 2: General Approach to Infectious Diseases
Chapter 3: Antibiotic Pharmacokinetics
Chapter 4: Antibiotic Pharmacodynamics
Chapter 5: Adverse Consequences of Antibiotic Use
Chapter 6: Antibiotic Resistance
Chapter 7: Beta-Lactams
	Penicillins
	Natural Penicillins
	Antistaphylococcal Penicillins
	Aminopenicillins
	Penicillin/Beta-lactamase Inhibitor Combinations
	Cephalosporins
	First-generation Cephalosporins
	Second-generation Cephalosporins
	Third-generation Cephalosporins
	Fourth-generation Cephalosporins
	Anti-MRSA Cephalosporins
	Siderophore Cephalosporin
	Cephalosporin/Beta-lactamase Inhibitor Combinations
	Carbapenems
	Carbapenem/Beta-lactamase Inhibitor Combinations
	Monobactams
Chapter 8: Glycopeptides and Short-Acting Lipoglycopeptides
Chapter 9: Long-Acting Glycopeptides
Chapter 10: Fluoroquinolones
Chapter 11: Aminoglycosides
Chapter 12: Tetracyclines and Modified Tetracyclines
Chapter 13: Macrolides
Chapter 14: Oxazolidinones
Chapter 15: Nitroimidazoles
Chapter 16: Nitrofurans and Fosfomycin
Chapter 17: Streptogramins
Chapter 18: Cyclic Lipopeptides
Chapter 19: Folate Antagonists
Chapter 20: Lincosamides
Chapter 21: Polymyxins
Chapter 22: Clostridioides difficile-Specific Agents
Chapter 23: Antimycobacterial Drugs
Chapter 24: Rifamycins
Chapter 25: Isoniazid
Chapter 26: Pyrazinamide
Chapter 27: Ethambutol
Chapter 28: Antifungal Drugs
Chapter 29: Polyenes
Chapter 30: Antifungal Antimetabolite
Chapter 31: Azoles
	Fluconazole
	Itraconazole
	Voriconazole
	Posaconazole
	Isavuconazole
Chapter 32: Echinocandins
Chapter 33: Terpenoids
Chapter 34: Antiviral Drugs
Chapter 35: Anti-Herpes Simplex Virus and Varicella-Zoster Virus Agents
Chapter 36: Anti-cytomegalovirus Agents
Chapter 37: Anti-influenza Antivirals
Chapter 38: Anti-coronavirus Antivirals
Chapter 39: Antiretroviral Drugs
	Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
	Non-nucleoside Reverse Transcriptase Inhibitors
	Protease Inhibitors
	Integrase Inhibitors
	Entry, Attachment, and Fusion Inhibitors
Chapter 40: Antiviral Interferons
Chapter 41: Direct-Acting Anti-hepatitis C Agents
Chapter 42: Ribavirin
Chapter 43: Hepatitis B Nucleoside Analogs
Chapter 44: Anti-SARS-CoV-2 Antibody Therapies
Chapter 45: Antiparasitic Drugs
Chapter 46: Quinolines
Chapter 47: Atovaquone
Chapter 48: Benzimidazoles
Chapter 49: Pentamidine
Chapter 50: Ivermectin
Chapter 51: Artemisinins
Appendix 1: Selected Normal Human Flora
Appendix 2: Spectrum of Activity
Appendix 3: Empiric Regimens for Common Infections
Index